6Burgos M, Gonzalez LC, Paz EA, Gournis E, Kawamura LM, Schecter G, Hopewell PC, Daley CL. Treatment of Muhidrug- Resistant Tuberculosis in San Francisco: an Outpatient-Based Approach[J]. Clin Infect Dis, 2005, 40(7):968-975.
7Chan ED, Laurel V, Strand MJ, Chan JF, Huynh ML, Ooble M, Iseman MD. Treatment and Outcome Analysis of 205 Patients with Multidrug-Resistant Tubereulosis[J]. Am J Respir Crit Care Med, 2004,169(10):103-9.
8Palmero DJ, Ambroggi M, Brea A, De Lueas M, Fulgenzi A, Martinez D, Mosea C, Musella R, Natiello M, Gonzalez C, Abbate E. Treatment and Follow-up of HIV-Negative Multi drug-Resistant Tuberculosis Patients in an Infectious Diseases Reference Hospital, Buenos Aires, Argentina[J]. Int J Tuberc Lung Dis, 2004, 8(6):778-784.
9Holtz TH, Sternberg M, Kammerer S, Laserson KF, Riekstina V, Zarovska E, Skripconoka V, Wells CD, Leimane V. Time to Sputum Culture Conversion in Multidrug-Resistant Tuberculosis: Predictors and Relationship to Treatment Outcome[J]. Ann Intern Med, 2006, 144(9):650-659.
10Tahaoglu K, Torun T, Sevim T, Atac G, Kir A, Karasulu L, Ozmen I, Kapakli N. The Treatment of Multidrug-Resistant Tuberculosis in Turkey[J]. N Engl J Med. 2001, 345(3):170 -174.
5Marra F, Marra CA, Bruchet N, et al. Adverse drug reactions associated with first line anti-tuberculosis drug regimens. Int J Tubere Lung Dis, 2007,11 (8) : 868-875.
